CELIX PHARMA LTD
London, United Kingdom
Registry record
| Company number | 12474195 |
|---|
| Status | Active |
|---|
| Legal form | Private Limited Company |
|---|
| Registered | 2020-02-20 |
|---|
| Address | LONDON E16 2DQ |
|---|
| Industry | 21200 - Manufacture of pharmaceutical preparations |
|---|
| Register | Companies House |
|---|
Adverse findings
As recorded by Companies House, in the register's own terms.
- Charges over assets — Outstanding charges over assets: 5 source
Public contracts
| Buyer | Contract | Value | Published |
|---|
| NHS England | Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin | £25.9M | 2025-11-26 |
| NHS England | Lot 1 - CM/TNS/25/5736 Nintedanib and Dalbavancin | £14.8M | 2026-02-25 |
| NHS England | NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | | 2026-04-24 |
| NHS England | NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | | 2026-01-30 |
Filed accounts
| Year | Revenue | Equity | Result |
|---|
| 2025 | | £1.5M | |